Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved publishing date : 2022 - 05 - 24 save search
Allegiance Bancshares, Inc. and CBTX, Inc. Shareholders Approve Merger
Published: 2022-05-24 (Crawled : 00:00) - globenewswire.com
ABTX | $41.63 0.0%
|
Finance
|
| O: -0.22%
H: 2.04%
C: -0.28%
Haymaker Acquisition Corp. III Announces Stockholder Approval of Business Combination with Biote
Published: 2022-05-24 (Crawled : 22:00) - globenewswire.com
HYAC 4 | $10.46 -0.1% -0.1% 22K
|
Finance
|
| O: 0.79%
H: 2.46%
C: -2.17%
acquisition approval
uniQure Announces FDA Acceptance of Biologics License Application for Etranacogene Dezaparvovec under Priority ReviewIf approved, etranacogene dezaparvovec would be the first gene therapy option for people living with hemophilia B
Published: 2022-05-24 (Crawled : 15:20) - biospace.com/
QURE | $4.68 -0.64% -0.64% 550K
|
Health Technology
|
| O: -1.35%
H: 8.88%
C: 7.74%
fda application license therapy living
Precipio Receives CE-IVD Certification to Market Multiple HemeScreen® Panels in EuropeThis Regulatory Approval Opens the Company’s Reach to the European Market
Published: 2022-05-24 (Crawled : 15:20) - biospace.com/
PRPO A | $6.72 0.07% 1.7K
|
Health Technology
|
| O: -0.93%
H: 13.2%
C: 1.88%
hemescreen approval market
BOX Pure Air Has Received First Initial Orders as an Approved Supplier for Multimillion Dollar Contract Offering in California to Address Indoor Air Quality in Non-Public Schools
Published: 2022-05-24 (Crawled : 13:20) - singlepoint.com
SING | $0.1739 -9.57% -0.98% 360K
|
|
| O: 0.0%
H: 8.89%
C: 3.4%
offering air california approved contract order
European Commission Approves KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Adjuvant Monotherapy After Surgery for Locally Advanced or Early-Stage Triple-Negative Breast Cancer at High Risk of Recurrence
Published: 2022-05-24 (Crawled : 12:00) - biospace.com/
MRK | News | $125.78 0.44% 0.0% 8.4M
|
Health Technology
|
| O: 0.8%
H: 0.58%
C: 0.41%
keytruda risk cancer breast cancer
MannKind’s Technosphere® Inhalation Platform Utilized in FDA-Approved Tyvaso DPI™
Published: 2022-05-24 (Crawled : 11:00) - biospace.com/
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 10.26%
H: 4.52%
C: 4.01%
MNKD | $4.19 2.7% 2.63% 1.8M
|
Health Technology
|
| O: 12.33%
H: 5.25%
C: -4.53%
technosphere platform fda
FDA Approves Dermavant’s VTAMA® (tapinarof) cream, 1% for the Treatment of Plaque Psoriasis in Adults: First Topical Novel Chemical Entity Launched for Psoriasis in the U.S. in 25 Years
Published: 2022-05-24 (Crawled : 11:00) - biospace.com/
ROIV | $10.46 0.97% 0.96% 4.7M
|
Manufacturing
|
| O: 5.21%
H: 4.82%
C: 1.82%
vtama treatment fda psoriasis tapinarof plague
United Therapeutics Announces FDA Approval of Tyvaso DPI™
Published: 2022-05-24 (Crawled : 11:00) - biospace.com/
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 10.26%
H: 4.52%
C: 4.01%
fda approval therapeutics
Amphastar Receives FDA Approval for Regadenoson
Published: 2022-05-24 (Crawled : 11:00) - biospace.com/
AMPH | $39.98 3.44% 3.33% 410K
|
Health Technology
|
| O: -0.98%
H: 1.84%
C: -0.96%
fda approval
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
KUKE | $2.88 2.49% 7.64% 360K
|
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
PVL 4 | $1.47 -0.68% 4.08% 77K
|
Energy Minerals
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
BSBR | $5.25 2.54% 0.38% 430K
|
Finance
DV | News | $29.43 -2.36% 0.24% 1.9M
|
Information
JOE 4 | $54.88 1.22% 0.22% 210K
|
Finance
JEF 4 | $42.17 1.57% 0.07% 1.8M
|
Finance
MUSA 4 | $417.23 1.06% 0.01% 170K
|
Retail Trade
Your saved searches
Save your searches and get alerts when important news are released.